Aspira Women's Health (AWH) Proxy filing summary

Executive summary

• Annual Meeting scheduled for June 17, 2026, to vote on director elections, executive compensation, stock plan amendment, and auditor ratification.

• Record date for voting is April 20, 2026, with 43,500,411 shares outstanding.

• Proxy materials and annual report are available online; voting encouraged by internet, phone, or mail.

Voting matters and shareholder proposals

• Six director nominees up for election for one-year terms expiring at the 2027 meeting.

• Advisory vote on executive compensation (say-on-pay) to be held.

• Proposal to amend the 2019 Stock Incentive Plan to increase authorized shares by 5,000,000.

• Ratification of BDO USA, P.C. as independent auditor for 2026.

• Shareholder proposals for 2027 must be submitted by December 24, 2026, for proxy inclusion.

Board of directors and corporate governance

• Board consists of six members with diverse backgrounds in healthcare, finance, and law.

• Board leadership structure separates Chair and CEO roles to reinforce independence.

• Committees: Audit, Compensation, and Nominating & Governance, all with independent members.

• Board and committee meetings held regularly; most directors attended at least 75% of meetings.

• Insider trading and hedging prohibited; Dodd-Frank compliant clawback policy in place.